Setva Turns a GLP-1 Dose Into a Weekly Curve

Field notes

The site explains a one-compartment dose model and places its assumptions beside the curve rather than hiding them behind a medical-sounding score. It uses roughly seven-day and five-day half-lives for semaglutide and tirzepatide, respectively, and proposes a seven-day moving average for weight. Symptom chips can be aligned to dose-cycle days, while dose logging is described across the phone, Lock Screen, Dynamic Island, and Apple Watch. The extract does not confirm App Store availability.